The growing prevalence of obesity, increasing diagnosis of weight-related chronic conditions, and expanding physician-led pharmacological interventions are supporting demand for appetite-control therapies. Greater emphasis on supervised weight management is also encouraging the use of regulated and clinically appropriate treatment options. The Anorexiants Market was valued at US$1,263.07...